Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00239343 | Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer | completed | Phase 2 | 160 | AstraZenecaINDUSTRY | 3 | Jan 27, 2011 | clinicaltrials |
| NCT00322348 | Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women | completed | Phase 2 | 98 | AstraZenecaINDUSTRY | 3 | Jan 24, 2011 | clinicaltrials |
| NCT00235937 |
| Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex |
| completed |
| Phase 2 |
| 45 |
| AstraZenecaINDUSTRY |
| 1 |
| Jan 21, 2011 |
| clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT00161291 | Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer | completed | Phase 2 | 28 | University of Alabama at BirminghamOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT01267552 | Study of Axillary Lymphadenectomy Without Drainage for Breast Cancer | completed | Phase 2 / Phase 3 | 240 | Universidade Federal de GoiasOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00357110 | Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer(@FAME) | completed | Phase 2 | 13 | AstraZenecaINDUSTRY | 3 | Dec 21, 2010 | clinicaltrials |
| NCT00480597 | Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer | completed | Phase 2 | 141 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT01203267 | Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer | completed | Phase 2 | 108 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT00524849 | Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis | completed | Phase 2 / Phase 3 | 60 | Fudan UniversityOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00705315 | Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00193115 | Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer | completed | Phase 2 | 32 | SCRI Development Innovations, LLCOTHER | 0 | Aug 4, 2010 | clinicaltrials |
| NCT00191789 | Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer | completed | Phase 2 | 65 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00196846 | Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) | completed | Phase 2 | 62 | GBG Forschungs GmbHOTHER | 1 | Jun 14, 2010 | clinicaltrials |
| NCT00006260 | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 36 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00440089 | Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors | completed | Phase 2 / Phase 3 | 76 | University of California, San DiegoOTHER | 1 | May 25, 2010 | clinicaltrials |
| NCT00410657 | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant | completed | Phase 2 | 53 | Fred Hutchinson Cancer CenterOTHER | 1 | May 14, 2010 | clinicaltrials |
| NCT00107484 | Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer | completed | Phase 2 | 3 | Virginia Commonwealth UniversityOTHER | 1 | May 3, 2010 | clinicaltrials |
| NCT00004013 | Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer | completed | Phase 2 | 60 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00004157 | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00010283 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00191269 | Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen | completed | Phase 2 | 68 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 17, 2010 | clinicaltrials |
| NCT00334802 | Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00186680 | CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant | completed | Phase 1 / Phase 2 | 99 | Stanford UniversityOTHER | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00191854 | Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line | completed | Phase 2 | 147 | Eli Lilly and CompanyINDUSTRY | 6 | Mar 2, 2010 | clinicaltrials |
| NCT00124111 | A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Feb 26, 2010 | clinicaltrials |
| NCT00533364 | Effect of SBG in Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Biotec Pharmacon ASAINDUSTRY | 1 | Feb 18, 2010 | clinicaltrials |
| NCT00509626 | Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy | completed | Phase 1 / Phase 2 | 380 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT01023204 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer | completed | Phase 2 | 68 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 4, 2010 | clinicaltrials |
| NCT00604435 | Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | completed | Phase 2 | 69 | Xijing HospitalOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00002937 | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 70 | City of Hope Medical CenterOTHER | 2 | Jan 6, 2010 | clinicaltrials |
| NCT00304850 | Polyamine-free Diet to Prevent Post Surgery Hyperalgesia(PoLyDOL) | completed | Phase 2 | 160 | University Hospital, BordeauxOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00303524 | Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | completed | Phase 2 | 170 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT01025349 | Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer | completed | Phase 2 | 20 | Taipei Medical University HospitalOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients | completed | Phase 1 / Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 20, 2009 | clinicaltrials |
| NCT00191451 | A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer | completed | Phase 2 | 150 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00333047 | Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy | completed | Phase 2 / Phase 3 | 24 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 11, 2009 | clinicaltrials |
| NCT00002679 | Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer | completed | Phase 2 | 89 | Yale UniversityOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00080743 | Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer | completed | Phase 2 | 2 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | completed | Phase 2 | 250 | Hospital San Carlos, MadridOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | completed | Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00287534 | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.(ARNO-95) | completed | Phase 2 | 1,059 | AstraZenecaINDUSTRY | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00096668 | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer | completed | Phase 2 | 47 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00306631 | A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 | completed | Phase 2 | 65 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 2 | May 29, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jan 27, 2011source: clinicaltrials